Hester Biosciences has informed that as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has arranged earnings conference call on Thursday, 28 October 2021 at 2:00 pm (IST) to discuss the standalone and consolidated unaudited financial results for the quarter and half year ended 30 September 2021.
The above information is a part of company’s filings submitted to BSE.